This program provides an overview and history of neurothrombectomy studies, thrombectomy in the extended time window, and methods for selecting appropriate patients. Discussion also addresses the 2018 guideline recommendations.
The results of the latest studies utilizing advanced brain imaging technology are changing the stroke treatment guidelines. The DEFUSE 3 study expands on the results of the MR CLEAN and DAWN studies, and allow for extended window for thrombectomies to as long as 24 hours in some cases. It also broadens the population eligible for clot-busting medication to people with mild strokes.
Neurothrombectomy: Improving Stroke Outcomes is an expanded education initiative comprising of three webinars that focuses on the latest research results and improving stroke outcomes.
For over 30 years we have been the trusted source for free resources and education to the stroke community. Together, we empower survivors and their circle of care to thrive after stroke. Make your tax-deductible donation today to support the growing needs of the stroke community.